A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin-Reference-Cited by-同舟云学术

A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin

Published:2016-09-08 Issue:1 Volume:86 Page:128-133
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Nilubol Naris¹,Merkel Roxanne¹,Yang Lily¹,Patel Dhaval¹,Reynolds James C.²,Sadowski Samira M.³,Neychev Vladimir⁴,Kebebew Electron¹

Affiliation:

1. Endocrine Oncology Branch; National Cancer Institute; National Institutes of Health; Bethesda MD USA

2. Nuclear Medicine Department; Clinical Research Center; National Institutes of Health; Bethesda MD USA

3. Thoracic and Endocrine Surgery; University Hospitals of Geneva; Geneva Switzerland

4. Department of Surgery; University Multiprofile Hospital for Active Treatment ‘Alexandrovska’; Medical University; Sofia Bulgaria

Funder

Intramural Research Program of the Center for Cancer Research

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13154/fullpdf

Reference33 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973-2002;Davies;JAMA,2006

2. Perspective: National cancer institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests;Hundahl;CA: A Cancer Journal for Clinicians,1998

3. Surgical reintervention for differentiated thyroid cancer;Goretzki;British Journal of Surgery,1993

4. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;Journal of Clinical Endocrinology and Metabolism,2006

5. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?;Ma;Journal of Nuclear Medicine,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy;Drug Resistance Updates;2023-05

2. Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity;Journal of Endocrinological Investigation;2023-04-13

3. Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment;Pharmaceuticals;2023-04-07

4. HDACs as an emerging target in endocrine tumors: a comprehensive review;Expert Review of Endocrinology & Metabolism;2023-03-04

5. Genomic and epigenomic profile of thyroid cancer;Best Practice & Research Clinical Endocrinology & Metabolism;2023-01